Moses Lake Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
JD & SN Inc. is recalling 91 vials of compounded testosterone pellets because the FDA cannot assure the sterility of the product.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text explicitly identifies the agency classification as Class II. According to the severity rubric, FDA Class II recalls are assigned a score of 4 (Severe), particularly when involving sterile compounded drugs where sterility assurance is lacking.
Plain-English summary
JD & SN Inc., doing business as Moses Lake Professional Pharmacy, is recalling 91 vials of Testosterone, Pellet, 112 mg, Rx only. The recall is being conducted because the U.S. Food and Drug Administration (FDA) cannot assure the sterility of the sterile human compounded drugs within their expiry dates.
The affected product was distributed nationwide. The recall covers specific lots identified by codes such as t12192014@18 and 11052014@20. The source text does not specify the exact number of units distributed per lot or the total number of patients affected.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on disposal or replacement. The FDA classifies this as a Class II recall, indicating a reasonable probability that use of the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- TESTOSTERONE, Pellet, 112 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Compounded Sterile Drug
- Affected units
- 91
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- t12192014@18
- t12092014@37
- t11252014@6
- t11192014@25
- t10212014@24
- t10172014@18
- t09252014@14
- t07162015@28
- t07152014@12
- t07062015@13
- t06042015@18
- t05282015@27
- t04242015@23
- t03192015@35
- t02242015@23
- t02192015@15
- t02062015@9
- t01292015@27
- 11052014@20
- 04102015@9.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility
See all →- SevereAurolab Trust Recalls FOCUS PI Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2026-10-07
- SevereSterling Recalls Carboxymethylcellulose Sodium Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereSterling Pharmaceutical Recalls Lubricating Tears Due to Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereWalgreens Lubricant Eye Drops Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2026-09-30
- SevereSodium Chloride Ophthalmic Solution Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
Similar recalls
- HighQualgen Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-11-14
- SevereQualgen Recalls Testosterone Pellets Due to Sterility Assurance Concerns
FDA (Drugs) · 2018-11-14
- SevereTestosterone Pellets Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- HighRecall of Testosterone 12.5mg Pellet due to Sterility Concerns
FDA (Drugs) · 2018-11-14
- HighPartell Specialty Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePharm D Solutions Recalls Testosterone Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19